Work

Tumour-specific fluorescence-guided surgery for pancreatic cancer using panitumumab-IRDye800CW: a phase 1 single-centre, open-label, single-arm, dose-escalation study

Year: 2020

Type: article

Study design: Clinical Trial

Source: The Lancet. Gastroenterology & hepatology

DOI: 10.1016/s2468-1253(20)30088-1

Authors: Guolan Lu, Nynke S van den Berg, Brock A Martin, Naoki Nishio, Zachary P Hart, Stan van Keulen, Shayan Fakurnejad, Stefania U Chirita, Roan C Raymundo, Grace Yi, Quan Zhou, George A Fisher, Eben L Rosenthal, George A Poultsides

Institutions: Stanford Medicine, Stanford University

Language: English

Topic: Pancreatic and Hepatic Oncology Research

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: green

Funders: Stanford University, Nederlandse Organisatie voor Wetenschappelijk Onderzoek, National Institutes of Health, National Cancer Institute, Stanford Cancer Institute

Awards: G4256020581, Prototype optical device for image guided surgery with panitumumab-IRDye800, Stanford Molecular Imaging Scholars (SMIS) Program

OpenAlex ID: W3024949407

FWCI: 4.332

Cites: 35

Cited by: 105

Related to: 10